TrademarkDir
CRITICUBE
DEAD

Serial Number

78808211

Owner

ASD SPECIALTY HEALTHCARE, INC.

Attorney

William A. Munck

Filing Date

Feb 6, 2006

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CRITICUBE Trademark

Serial Number: 78808211

CRITICUBE is a trademark filed by ASD SPECIALTY HEALTHCARE, INC. on February 6, 2006. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ASD SPECIALTY HEALTHCARE, INC. (28 trademarks)

3101 Gaylord Parkway
Frisco, TX 75034

Entity Type: 03

Trademark Details

Filing Date

February 6, 2006

Registration Date

Not Registered

Published for Opposition

September 19, 2006

Goods & Services

Pharmaceutical management services for others; namely, inventory management, replenishing and resetting services and automated inventory monitoring services

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 15, 2008 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 15, 2008 ABN6
SOU EXTENSION 2 GRANTED
Dec 12, 2007 EX2G
SOU EXTENSION 2 FILED
Dec 12, 2007 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 12, 2007 EEXT
SOU EXTENSION 1 GRANTED
Aug 28, 2007 EX1G
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 11, 2007 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 11, 2007 COAR
SOU EXTENSION 1 FILED
Jun 8, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2007 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2006 NOAM
PUBLISHED FOR OPPOSITION
Sep 19, 2006 PUBO
NOTICE OF PUBLICATION
Aug 30, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 3, 2006 PREV
ASSIGNED TO LIE
Jul 28, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 26, 2006 CNSA
ASSIGNED TO EXAMINER
Jul 26, 2006 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 19, 2006 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 19, 2006 PARI
NEW APPLICATION ENTERED
Feb 13, 2006 NWAP

Related Trademarks

More from this Owner

INNOVATION CANCER

INNOVATION CANCER

INNOVATION CANCER

INNOVATION CANCER

INNOVATION CANCER

INNOVATION CANCER

TOMORROW, TOGETHER

TOMORROW, TOGETHER

TOMORROW, TOGETHER

TOMORROW, TOGETHER

CUBIXX

CUBIXX